29.0001.75% ( +0.500 )
Trading: Nov 16, 13:14:25 (EDT)Overview
Windward Bio Group AG (WWB)
Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and de...
- Open
- 25.000
- High
- 29.200
- Low
- 22.500
- Prev. Close
- 28.500
- Volume
- 181.59K
- Turnover
- 4.60M
- Avg Price
- 25.320
- Bid/Ask Ratio
- -33.33%
- Amplitude
- 23.51%
- 52wk High
- 33.985
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.48%
- 52wk Low
- 18.350
- Float Mkt Cap
- 1.10B
- Market CapUSD
- 1.68B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.18
- EPSDynamic
- -1.47
- EPSStatic
- --
- BVPS
- 4.58
- P/B
- 6.33
- Circulating Supply
- 38.04M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 58.04M
- Min lot size
- 1
- Currency
- USD
News
benzinga_article · Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
PUBT · Windward Bio prices $175 million Nasdaq IPO
RenaissanceCapital · US IPO Weekly Winners & Losers
Simplywall · 2 Reasons Windward Bio Group (WWB) Looks Pricey Following Its Shelf Filing
PR Newswire · Innovative Immunology Biotech Windward Bio Lists on Nasdaq
TradingView · Windward Bio Shares Close 68% Above $17 IPO Price
